Section He-P 301.12 - Procedures for Written Orders(a) Upon receiving a report that a person has a communicable disease, is suspected of having a communicable disease or has been exposed to a communicable disease, the department shall promptly commence an investigation into the matter in order to confirm the report.(b) Upon confirming the report, the department shall make a determination, based on the best available guidance and recommendations from the Centers for Disease Control and Prevention or other established sources, as to whether the circumstances of the case require that the affected person be maintained in isolation or quarantine, undergo a medical examination, or receive medical treatment.(c) All orders of isolation, quarantine or treatment shall be issued in accordance with RSA 141-C:11 and 12, except that written orders for treatment shall include the reason for and nature of the medical treatment, where that treatment will be provided, and the duration of time for which the person will need to undergo the treatment.(d) If the person subject to an order of treatment cannot be removed to a health care provider or to a health care facility for treatment without danger to his life or to the citizenry, the commissioner shall impose isolation or quarantine under RSA 141-C:11 and shall arrange for treatment and care as necessary to mitigate the threat.(e) The cost of treatment and care, except treatment provided under RSA 141-C:15, III, shall be in accordance with RSA 141-C:15, IV.(f) Action taken to enforce an order of isolation, quarantine or treatment shall be consistent with the provision of RSA 141- C:13, 14 and 15.(g) All persons who are subject to orders of isolation, quarantine or treatment shall be entitled to the due process rights set for in RSA 141-C:14-a.N.H. Code Admin. R. He-P 301.12
#4425, eff 5-27-88; ss by #4946, eff 10-2-90; EXPIRED: 10-2-96
New. #6634, eff 11-25-97; ss by #8242, eff 12-30-04; ss by #9172, eff 6-6-08
Amended by Volume XXXVI Number 45, Filed November 10, 2016, Proposed by #12033, Effective 11/3/2016, Expires 11/3/2026.